europeanpharmaceuticalreviewMay 23, 2019
Tag: ICS , Steriline , intelligent , Systems
As a single-source supplier of equipment solutions for the primary packaging of injectable drugs, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for the aseptic processing.
These applications are compatible with vials, ampoules, cartridges, and syringes and can handle toxic or non-toxic products in both liquid and powder form.
Steriline’s complete lines include equipment spanning from washing machines, depyrogenation tunnels, filling and capping machines to external decontamination machines and barrier systems such as LAF, oRABS, cRABS and isolators.
Quality and sustainability
In 2015 Steriline has been certified ISO 9001:2008 and in 2018 ISO 9001:2015 and fulfils quality management system requirements, covering all production processes and organisational procedures to continuously improve customer satisfaction. Steriline is also compliant with cGMP, GAMP and 21CFRPart11 requirements. Moreover, Steriline places high relevance on protecting the environment and adoptssustainable business practices. The company complies with all applicable legislations regarding the environment and works economically and responsibly with resources.
Focus on the intelligent compounding system
The intelligent compounding system (ICS) is a fully automated robotic solution, controlled by software, which compounds parenteral medication doses into the appropriate final containers within a controlled (ISO class 4.8, grade A) environment.
The ICS is for use within the compounding practices, both in hospitals and compounding centres, to prepare injections in accordance with appropriate regulations and to label final products in accordance with good practice requirements. It is based on isolator technology and includes a bio-decontamination system with vaporised H2O2 sterilisation technology; it can therefore be installed in an ISO class 8 (grade D) background environment, as per GMP Annex 1.
The ICS can handle both hazardous and non-hazardous medications and both patient specific and batch production.
Register as Visitor to CPhI China 2019 NOW!
-----------------------------------------------------------------------
Editor's Note:
If you have any suggestion to the content,
please email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: